期刊文献+

大鼠脊柱融合模型中BBP增强BMP-2的骨诱导作用 被引量:5

Adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone heal in a rodent spinal fusion model
原文传递
导出
摘要 [目的]验证在大鼠脊柱融合模型中BBP对于rhBMP-2骨诱导作用的影响。[方法]采取Lewis大鼠的脊柱后外侧横突间融合模型,在胶原海绵为载体的rhBMP-2中加入BBP并减少rhBMP-2的用量,测试两种不同剂量的BBP(500 ug和1 000 ug)有或无低剂量的rhBMP2(1 ug)时的骨融合效果,并与单纯的低剂量rhBMP-2(1 ug)组相对比。融合效果采用手工评估,影像学评分,Micro-CT评估和组织学评估4种方法。[结果]BBP本身不管是低剂量还是高剂量均不能诱导骨融合。BBP复合低剂量BMP-2不能完全取得与高剂量BMP-2完全相同的效果,但可以减少BMP-2的用量。加入BBP的低剂量BMP-2组显然较低剂量BMP-2组融合率高,而且与高剂量BMP-2组的融合率相近,而且BBP的低剂量BMP-2组显然较低剂量BMP-2组融合的要早。[结论]在大鼠的脊柱融合模型中,BBP本身不管是低剂量还是高剂量均不能诱导骨融合。BBP可以增强BMP-2的骨形成作用,提高融合率,降低BMP-2的使用剂量以及减少了剂量相关性副作用的发生率,但不能取得与高剂量BMP-2完全相同的效果。BBP可以减少脊柱融合所需的时间和提高形成骨的质量。进一步的研究可以优化BBP和BMP-2的剂量,从而为以后的临床手术应用中取得更好的融合效果。 [ Objective] A prospective 8 -week interventional trial employing a rat model of spinal fusion was made to test the effect on bone morphogenetic protein binding peptide (BBP) on rhBMP -2 induced bone healing. [ Methods] Posterolateral intertransverse process spinal fusion at L4,5 was performed in Lewis rats. Two doses of BBP (500 ug, and 1 000 rag) were tested with or without "low dose" (1 ug) rhBMP- 2 and the results were compared with the low dose (1 ug) rhBMP -2. Fusion was evaluated by radiology, histology, and manual palpation tests. [ Results ] Radiology revealed significant earlier fusion with 1 000 mg BBP and 1 ug BMP -2 combination when compared with low dose BMP -2 (1 ug) only (P 〈0.05) . Manual palpation and histology at eighth week revealed higher rate of fusion with the same combination with a nearly significant difference (P = 0. 057) . [ Conclusion ] Specific growth factor binding agents, such as BBP, can be compounded into carriers used in fusion procedures to decrease the dosage of BMP and possiblely decrease the side effects which are most likely.
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2013年第3期260-266,共7页 Orthopedic Journal of China
基金 中国博士后基金面上资助项目(编号:2011M501365) 深圳市重点实验室提升项目(编号:CXB201104220049A) 国家留学基金委员会公派留学资助项目
关键词 RHBMP-2 BBP 脊柱融合 rhBMP -2, bone binding peptide, spinal fusion
  • 相关文献

参考文献26

  • 1Glassman SD,Carreon LY,Campbell M J. The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion[J].Spine Journal,2008.443-448.
  • 2Vaidya R,Carp J,Sethi A. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2[J].European Spine Journal,2007.1257-1265.
  • 3Woo EJ. Expanded indication for recombinant human bone morphogenetic protein 2[J].Spine,2011.1817.
  • 4Abd-El-Barr MM,Cox JB,Antonucci MU. Recombinant human bone morphogenetic protein-2 as an adjunct for spine fusion in a pediatric population[J].Pediatric Neurosurgery,2011.266-271.
  • 5Lee JW,Lee S,Lee SH. Improved spinal fusion efficacy by long-term delivery of bone morphogenetic protein-2 in a rabbit model[J].ACTA ORTHOPAEDICA,2011.756-760.
  • 6Matsumoto T,Toyoda H,Dohzono S. Efficacy of interspinous process lumbar fusion with recombinant human bone morphogenetic protein-2 delivered with a synthetic polymer and β-tricalcium phosphate in a rabbit model[J].European Spine Journal,2012.1338-1345.
  • 7Perri B,Cooper M,Lauryssen C. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion:a case study[J].Spine Journal,2007.235-239.
  • 8Smucker JD,Rhee JM,Singh K. Increased swelling complications as-sociated with off-label usage of rhBMP-2 in the anterior cervical spine[J].Spine,2006.2813-2819.
  • 9Shields LB,Raque GH,Glassman SD. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervicalspinefusion[J].Spine,2006.2029-2030.
  • 10Lu SS,Zhang X,Soo C. The osteoinductive properties of Nell-1 in a rat spinal fusion model[J].Spine Journal,2007.50-60.

同被引文献96

  • 1蒋电明,权正学,欧云生,倪卫东,梁熙,孟纯阳.纳米羟基磷灰石/聚酰胺66复合生物活性人工椎体在胸腰椎爆裂骨折中的应用[J].中华创伤杂志,2006,22(12):884-887. 被引量:31
  • 2韩冬,李建军,孙鸿斌,李春雨,王悦书.骨形态发生蛋白-2腺病毒表达载体在成骨过程中与血管内皮细胞生长因子关系[J].中国矫形外科杂志,2007,15(9):698-701. 被引量:5
  • 3Glassman SD, Carreon LY, Campbell MJ, et al. The perioperativecost of infuse bone graft in posterolateral lumbar spine fusion [ J ].Spine J,2008,8: 443 -448.
  • 4Lissenberg-Thunnissen SN,de Gorter DJ, Sier CF,et al. Use andefficacy of bone morphogenetic proteins in fracture healing [ J]. IntOrthop,2011 ,9:1271 -1280.
  • 5Woo EJ. Expanded indication for recombinant human bone morpho-genetic protein 2[ J]. Spine’2011,21:1817.
  • 6Abd-El-Barr MM, Cox JB, Antonucci MU, et al. Recombinant hu-man bone morphogenetic protein -2 as an adjunct for spine fusion ina pediatric population[J]. Pediatr Neurosurg,2011,4:266 -271.
  • 7Lee JW, Lee S, Lee SH, et al. Improved spinal fusion efficacy bylong-term delivery of bone morphogenetic protein-2 in a rabbit model[J]. Acta Orthop,2011,6:756 -760.
  • 8Matsumoto T, Toyoda H, Dohzono S, et al. Efficacy of interspinousprocess lumbar fusion with recombinant human bone morphogeneticprotein-2 delivered with a synthetic polymer and 3~tricalcium phos-phate in a rabbit model[ J]. Eur Spine J,2012,7 :1338 - 1345.
  • 9Song G, Habibovic P, Bao C, et al. The homing of bone marrowMSCs to non-osseous sites for ectopic bone formation induced by os-teoinductive calcium phosphate [ J ]. Biomaterials, 2013 ,9 : 2167 -2176.
  • 10Smucker JD, Rhee JM, Singh K, et al. Increased swelling complica-tions as sociated with off-label usage of rhBMP-2 in the anterior cervi-cal spine[ J]. Spine,2006,31 :2813 -2819.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部